[Clinical and experimental effect of potassium cardiac glycoside and atropine preparations on the action of difibrillating currents on the heart].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000628:therapy; D001285:Atropine / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004285:Dogs; D004554:Electric Countershock; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008722:Methods; D011188:Potassium / Q000627:therapeutic use*; D011292:Premedication; D013328:Strophanthins / Q000009:adverse effects / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000628:therapy
D002301:Cardiac Glycosides; D013328:Strophanthins; D001285:Atropine; D011188:Potassium
Vliianie preparatov kaliia, serdechnykh glikozidov i atopina na deĭstvie defibrilliruiushchego razriada na serdtse v klinike i éksperimente.